Get my own profile
Public access
View all7 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Reyer ZwiggelaarDepartment of Computer Science, Aberystwyth UniversityVerified email at aber.ac.uk
- Yinyin YuanThe Institute of Cancer Research, LondonVerified email at icr.ac.uk
- Andrik RampunPostdoc Research Associate, Sheffield University, UKVerified email at sheffield.ac.uk
- Talha QaiserAstraZenecaVerified email at astrazeneca.com
- Faranak SobhaniInstitute of Cancer Research (ICR), London, UKVerified email at icr.ac.uk
- Otar AkanyetiSenior Lecturer in Aberystwyth UniversityVerified email at aber.ac.uk
- Daniel MarksExecutive Medical Director, AstraZeneca; Consultant Physician, University College London Hospital; Honorary Associate Professor, University College LondonVerified email at ucl.ac.uk
- Bastian Robert AngermannPrinciple Scientist, AstraZenecaVerified email at astrazeneca.com
- Ulf GehrmannPostdoc, Institut Curie, ParisVerified email at curie.fr
- hibret adissuVerified email at nih.gov
- Aboozar GhaffariIran University of Science and TechnologyVerified email at iust.ac.ir
- Chuan LuAberystwyth universityVerified email at aber.ac.uk
- John H DoonanProfessor of Genetics, National Plant Phenomics Centre, Aberystwyth UniversityVerified email at aber.ac.uk
- Morteza GhahremaniAIVerified email at tum.de
- Fiona CorkeAberystwyth UniversityVerified email at aber.ac.uk
- Gina Garzón-MartínezColombian Corporation for Agricultural Research-AGROSAVIAVerified email at agrosavia.co
- Jessica NeisenAstraZenecaVerified email at astrazeneca.com
- Carlo C. MaleyBiodesign Institute, Arizona State UniversityVerified email at asu.edu
- Jeffrey R. MarksDuke UniversityVerified email at mc.duke.edu
- Hugo M. HorlingsMD PhD, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The NetherlandsVerified email at nki.nl